Trial Outcomes & Findings for MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex (NCT NCT01450397)
NCT ID: NCT01450397
Last Updated: 2017-04-17
Results Overview
Change in Volume (millimeter cubed) of the Cord by MRI between Baseline and 30 days after XIAFLEX injection and manual manipulation.
Recruitment status
COMPLETED
Study phase
PHASE4
Target enrollment
5 participants
Primary outcome timeframe
Baseline and 30 days
Results posted on
2017-04-17
Participant Flow
Subjects were enrolled from July 2011 to December 2011. Enrollment was completed in a medical clinic.
Participant milestones
| Measure |
XIAFLEX
0.58 mg of Xiaflex injected into a palpable Dupuytren's cord
|
|---|---|
|
Overall Study
STARTED
|
5
|
|
Overall Study
COMPLETED
|
5
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex
Baseline characteristics by cohort
| Measure |
XIAFLEX
n=5 Participants
Patient who have received XIAFLEX
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
1 Participants
n=99 Participants
|
|
Age, Categorical
>=65 years
|
4 Participants
n=99 Participants
|
|
Age, Continuous
|
67.6 years
STANDARD_DEVIATION 5.5 • n=99 Participants
|
|
Sex: Female, Male
Female
|
0 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
5 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: Baseline and 30 daysChange in Volume (millimeter cubed) of the Cord by MRI between Baseline and 30 days after XIAFLEX injection and manual manipulation.
Outcome measures
| Measure |
XIAFLEX
n=5 Participants
Subjects receiving one Xiaflex injection
|
|---|---|
|
The Measured Change in Volume of the Cord by MRI Before and After XIAFLEX Injection and Manual Manipulation.
|
482 mm^3
Interval 188.0 to 670.0
|
Adverse Events
XIAFLEX
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place